Related Experiment Video

Updated: Aug 9, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 28, 2010

Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis

U Ritter1, H Moll, T Laskay

  • 1Infectious Diseases Research Center, University of Würzburg, Germany.

The Journal of Infectious Diseases
|March 1, 1996
PubMed

Insights

Localized cutaneous leishmaniasis (LCL) shows high macrophage chemoattractant protein-1 (MCP-1), aiding healing. Diffuse cutaneous leishmaniasis (DCL) has predominant macrophage inflammatory protein-1 alpha (MIP-1 alpha), linked to non-healing.

Area of Science:

  • Immunology
  • Dermatology
  • Parasitology

Background:

  • Cutaneous leishmaniasis (CL) presents in localized (LCL) and diffuse (DCL) forms, with distinct immune cell infiltration patterns.
  • Understanding the chemokine-mediated recruitment of macrophages and T cells is crucial for CL pathogenesis.

Purpose of the Study:

  • To investigate the expression profiles of key chemokines in LCL and DCL lesions.
  • To correlate specific chemokine expression with disease forms and outcomes.

Main Methods:

  • Analysis of chemokine expression (MCP-1, MIP-1 alpha, MIP-1 beta, RANTES, I-309, IL-8) in skin lesions from LCL and DCL patients.
  • Comparison of chemokine levels between LCL and DCL patient groups.

Main Results:

  • LCL lesions exhibited high levels of macrophage chemoattractant protein-1 (MCP-1) and moderate macrophage inflammatory protein-1 alpha (MIP-1 alpha).
  • DCL lesions showed significantly lower MCP-1 expression and predominant MIP-1 alpha expression.
  • Other investigated chemokines were minimally expressed or absent in both forms.

Conclusions:

  • MCP-1 and MIP-1 alpha are key chemokines involved in macrophage and T cell recruitment in cutaneous leishmaniasis.
  • Higher MCP-1 levels in LCL may contribute to macrophage activation and self-healing.
  • Predominant MIP-1 alpha in DCL is associated with non-healing and disease progression.

More Related Videos

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs11:36

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Published on: April 21, 2012

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...